4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine compounds corresponding to the formula I ##STR00001## a method for producing them, pharmaceutical compositions containing them, and methods of using them to treat or inhibit pain or other specified conditions associated with the ORL1 receptor.